1. Burger, J. J., Tomlinson, E., Mulder, E. M. A. and McVie, J. G., Albumin microspheres for intra-arterial tumour targeting. I. Pharmaceutical aspects.Int. J. Pharm., 23, 333–344 (1985).
2. Cho, C. S. and Kim, S. U.In vitro degradation of biodegradable poly(γ-benzyl L-glutamate)/poly(ethylene glycol) block copolymers.J. Contr. Res., 7, 283–286 (1988).
3. Cho, C. S., Kim, S. W. and Komoto, T. Synthesis and structural study on an ABA block copolymer consisting of poly(γ-benzyl L-glutamate) as the A block and poly(ehtylene oxide) as the B block.Makromol. Chem., 191, 981–991 (1990).
4. Cho, C. S., Park, J. W., Kwon, J. K., Jo, B. W., Lee, K. C., Kim, K. Y. and Sung, Y. K. Release of cytarabine from biodegradable poly(γ-benzyl L-glutamate) /poly(ethylene oxide)/poly(γ-benzyl L-glutamate) block copolymer microsphere.Polymer (Korea), 15, 27–33 (1991).
5. Cho, C. S., Kwon, J. K., Jo, B. W., Lee, K. C. and Sung, Y. K., Release of cytarabine from poly(ε-carbobenzoyl L-lysine)/poly(ethylene oxide)/poly(ε-carbobenzoxy L-lysine) block copolymer microsphere.J. Kor. Pharm. Sci. 22, 323–326 (1992).